Your R&D team is crushing timelines for ushering a new
molecular entity to market—the market has taken notice
and your team is recognized as a first-in-class organization for its scientific, medical and technical strategy and execution. The business team has just added two new assets to the
pipeline and their trusted contract research organization (CRO)
is showing signs it may not meet future expectations. The team
hastily issues a Request for Proposal (RFP) at a moment of vulnerability, and the supply market knows it. Their desire to consider alternate CRO options raises the possibility the company
is at risk of missing key development dates that could adversely
impact the future of your young and emerging company.

Download Attachment

See all Member News